Bill
HB 2385
Oregon law restricts 340B covered entities' use of federal drug discount programs, limiting how hospitals can leverage medication discounts for financial or operational purposes.
HB 2385 imposes restrictions on how 340B covered entities—hospitals and health systems that receive discounted drug pricing under the federal 340B program—can operate their drug discount programs in Oregon. The bill limits eligibility and usage of these discounts, likely requiring covered entities to demonstrate greater transparency or clinical justification for their participation in the program.
The 340B program allows eligible healthcare providers to purchase medications at significant discounts, theoretically to serve uninsured and low-income patients. However, the program has faced scrutiny for potential abuse, where some entities use discounts primarily for profit rather than patient benefit. This bill addresses concerns that Oregon covered entities may be expanding beyond their intended mission or using discounts inefficiently.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
